Abstract:Protein synthesis is essential for cell growth, proliferation, and survival. Protein synthesis is a tightly regulated process that involves multiple mechanisms. Deregulation of protein synthesis is considered as a key factor in the development and progression of a number of diseases, such as cancer. Here we show that the dynamic modification of proteins by O-linked β-N-acetyl-glucosamine (O-GlcNAcylation) regulates translation initiation by modifying core initiation factors eIF4A and eIF4G, respectively. Mechanistically, site-specific O-GlcNAcylation of eIF4A on Ser322/323 disrupts the formation of the translation initiation complex by perturbing its interaction with eIF4G. In addition, O-GlcNAcylation inhibits the duplex unwinding activity of eIF4A, leading to impaired protein synthesis, and decreased cell proliferation. In contrast, site-specific O-GlcNAcylation of eIF4G on Ser61 promotes its interaction with poly(A)-binding protein (PABP) and poly(A) mRNA. Depletion of eIF4G O-GlcNAcylation results in inhibition of protein synthesis, cell proliferation, and soft agar colony formation. The differential glycosylation of eIF4A and eIF4G appears to be regulated in the initiation complex to fine-tune protein synthesis. Our study thus expands the current understanding of protein synthesis, and adds another dimension of complexity to translational control of cellular proteins.

Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation.

O-GlcNAcylation of Core Components of the Translation Initiation Machinery Regulates Protein Synthesis.

Eukaryotic Translation Initiation Factors and Tumor

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

Translational Regulator Eif2α in Tumor

Translation initiation factor eIF4G1 modulates assembly of the polypeptide exit tunnel region in yeast ribosome biogenesis

eIF3d: A driver of noncanonical cap–dependent translation of specific mRNAs and a trigger of biological/pathological processes

Eukaryotic translation initiation factors and cancer.

Insights into eukaryotic translation initiation factor 5A: Its role and mechanisms in protein synthesis

Critical and differential roles of eIF4A1 and eIF4A2 in B-cell development and function

eIF4E-independent translation is largely eIF3d-dependent

Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers

Eukaryotic Translation Initiation Factor 3 and Tumor

eIF4G-driven translation initiation of downstream ORFs in mammalian cells

Recent research progress of eIF3 in biological function

The Biological Roles Of Translation Initiation Factor 3b

Eukaryotic initiation factors eIF4F and eIF4B promote translation termination upon closed-loop formation

Research Progress and Prospect of Eukaryotic Initiation Factor 4A (eIF4A)

Increased levels of eIF2A inhibit translation by sequestering 40S ribosomal subunits